The treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol
- 1 December 1976
- journal article
- Published by Springer Nature in Calcified Tissue International
- Vol. 22 (S1) , 112-116
- https://doi.org/10.1007/bf02064050
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- EFFECTS OF 1,25-DIHYDROXYCHOLECALCIFEROL ON CALCIUM ABSORPTION, MUSCLE WEAKNESS, AND BONE DISEASE IN CHRONIC RENAL FAILUREThe Lancet, 1974
- The Kidney as an Endocrine Organ for the Production of 1,25-Dihydroxyvitamin D3, a Calcium-Mobilizing HormoneNew England Journal of Medicine, 1973
- Particle body neutron activation analysis in vivo: A new approach to the investigation of metabolic bone diseasePhysics in Medicine & Biology, 1973
- FAILURE OF FORMATION OF 1,25-DIHYDROXYCHOLECALCIFEROL IN CHRONIC RENAL INSUFFICIENCYThe Lancet, 1973
- Effect of dihydrotachysterol on calcium absorption in uremiaMetabolism, 1972
- IMMUNORADIOMETRIC ASSAY OF PARATHYROID HORMONEJournal of Endocrinology, 1971
- BONE DISEASE IN CHRONIC RENAL FAILUREQJM: An International Journal of Medicine, 1963
- Genetics, hypersensitivity and the connective tissue diseasesThe American Journal of Medicine, 1961
- THE TREATMENT OF RENAL-GLOMERULAR OSTEODYSTROPHYQJM: An International Journal of Medicine, 1961
- STUDIES OF CALCIUM AND PHOSPHORUS METABOLISM WITH SPECIAL REFERENCE TO PATHOGENESIS AND EFFECTS OF DIHYDROTACHYSTEROL (A.T.10) AND IRONMedicine, 1943